半规管填塞术与鼓室内注射庆大霉素治疗梅尼埃病的试验
单中心、开放标签、随机非劣效性试验纳入66例梅尼埃病患者,比较半规管填塞术(TSCP)与鼓室内注射庆大霉素,随访24个月。TSCP组有效眩晕控制率97%非劣于庆大霉素组85%(p值=0.012,95%CI=-2.8%至27.1%),且TSCP组在听前庭症状量表、头晕残障量表及功能水平量表评分上改善更明显,平衡恢复时间更短。
要点
- TSCP组有效眩晕控制率97%非劣于鼓室内庆大霉素组85%(p值=0.012,95%CI=-2.8%至27.1%)。
- TSCP组在VSS(5.7,95%CI=0.30-11.0,p值=0.038)、DHI(10.7,95%CI=3.1-18.3,p值=0.006)和FLS(0.5,95%CI=0.1-1.0,p值=0.025)上改善优于庆大霉素组。
- TSCP组视频头脉冲试验(p值=0.001)和冷热试验(p值<0.001)显示半规管功能显著降低,但耳石反应更保留,平衡恢复中位时间更短(p值<0.001)。
核心结论
- TSCP组有效眩晕控制率非劣于鼓室内注射庆大霉素组,且眩晕控制率更高。
研究设计与样本
- 单中心、开放标签、随机非劣效性试验,纳入66例梅尼埃病患者,随机分为TSCP组33例和鼓室内注射庆大霉素组33例,随访24个月。
主要发现
- TSCP组有效眩晕控制率97%,鼓室内庆大霉素组85%(p值=0.012,95%CI=-2.8%至27.1%)。
- TSCP组较庆大霉素组在VSS评分上改善5.7(95%CI=0.30-11.0,p值=0.038),DHI评分改善10.7(95%CI=3.1-18.3,p值=0.006),FLS评分改善0.5(95%CI=0.1-1.0,p值=0.025)。
- TSCP组视频头脉冲试验(p值=0.001)和冷热试验(p值<0.001)显示半规管功能显著降低,耳石反应更保留。
- TSCP组平衡恢复中位时间显著短于庆大霉素组(p值<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Menière's disease (MD) can lead to disabling vertigo attacks with hearing loss. Triple semicircular canal plugging (TSCP) surgery is a new treatment for MD, but high-quality evidence is scarce. This study aimed to assess the long-term efficacy and safety of TSCP. METHODS: In a single-center, open-label, randomized non-inferiority trial, MD patients were assigned to either TSCP or intratympanic gentamicin injections, with 24 months of follow-up. The primary outcome measure was the effective vertigo control rate. Secondary outcome measurements included the mean and median number of vertigo attacks post-intervention, audiovestibular symptom scale scores, audiovestibular test results, and time to balance recovery. RESULTS: A total of 66 patients (33 TSCP and 33 gentamicin) were randomized. The effective vertigo control rate in the TSCP group (97%) was non-inferior to the gentamicin group (85%) (p value = 0.012,95% CI = -2.8% to 27.1%). The TSCP group showed more improvement in audiovestibular symptoms compared to the gentamicin group, regarding the VSS (5.7, 95% CI = 0.30-11.0, p value = 0.038), DHI (10.7, 95% CI = 3.1-18.3, p value = 0.006), and FLS (0.5, 95% CI = 0.1-1.0, p value = 0.025). Semicircular canal function was significantly reduced in TSCP, as measured by video Head Impulse Testing (p value = 0.001) and the caloric test (p value < 0.001). Otolith responses were more preserved in the TSCP group. The TSCP group demonstrated a significantly shorter median time to balance recovery (p value < 0.001). CONCLUSION: The effective vertigo control rate in the TSCP group is non-inferior to intratympanic gentamicin, with a higher vertigo control rate. TRIAL REGISTRATION: ChiCTR1900023606 LEVEL OF EVIDENCE: 2.
引用
- Zhang D, Li X, Van de Berg R, et al. A Trial of Semicircular Canal Plugging vs. Intratympanic Gentamicin for Menière's Disease. Laryngoscope. 2025. PMID: 40607682. doi:10.1002/lary.32400
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。